The number of MR procedures is continuing to grow, especially on the heels of the increasing popularity of MR angiography. Overall procedure growth, however, has begun to slow compared with previous years' performance, according to Arlington Medical
The number of MR procedures is continuing to grow, especially on the heels of the increasing popularity of MR angiography. Overall procedure growth, however, has begun to slow compared with previous years' performance, according to Arlington Medical Resources. An estimated 24.9 million MR procedures were performed in 2003 at more than 5700 U.S. hospitals and freestanding diagnostic imaging centers, the research company said. Brain studies were the most popular. In the 3.4 million MR exams performed with contrast, Magnevist was the agent most frequently used.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.